+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Psoriatic Arthritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768146
  • Report
  • 228 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Celgene Corp
  • Eli Lilly and Co
  • Johnson & Johnson
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Psoriatic Arthritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Psoriatic Arthritis. It presents in-depth analysis of Psoriatic Arthritis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Psoriatic Arthritis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Psoriatic Arthritis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Psoriatic Arthritis

The research work is prepared through extensive and continuous research on Psoriatic Arthritis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Psoriatic Arthritis patients are identified
  • The report includes panorama of Psoriatic Arthritis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Psoriatic Arthritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Celgene Corp
  • Eli Lilly and Co
  • Johnson & Johnson
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Psoriatic Arthritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Psoriatic Arthritis Clinical Trials by Region
2.2.2 Average Enrollment of Psoriatic Arthritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Psoriatic Arthritis Treatment, 2019

3. Region wise Psoriatic Arthritis Clinical Trials
3.1 Asia Pacific Psoriatic Arthritis Clinical Trials by Country
3.2 Europe Psoriatic Arthritis Clinical Trials by Country
3.3 North America Psoriatic Arthritis Clinical Trials by Country
3.4 Middle East and Africa Psoriatic Arthritis Clinical Trials by Country
3.5 South and Central America Psoriatic Arthritis Clinical Trials by Country

4. Psoriatic Arthritis Clinical Trial Trends
4.1 Start Year wise Psoriatic Arthritis Clinical Trials
4.2 Phase wise Psoriatic Arthritis Clinical Trials
4.3 Trial Status wise Psoriatic Arthritis Clinical Trials
4.4 Trial Type wise Psoriatic Arthritis Clinical Trials

5. Psoriatic Arthritis Average Enrollment Trends
5.1 Average Enrollment in Psoriatic Arthritis Trials by Year
5.2 Average Enrollment in Psoriatic Arthritis Trials by Phase
5.3 Average Enrollment in Psoriatic Arthritis Trials by Status
5.4 Average Enrollment in Psoriatic Arthritis Trials by Type of Trial

6. Companies Participating in Psoriatic Arthritis Clinical Trials
6.1 Psoriatic Arthritis Trials by Sponsor Type
6.2 Psoriatic Arthritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Psoriatic Arthritis Trials- Phase 1
7.2 Psoriatic Arthritis Trials- Phase 2
7.3 Psoriatic Arthritis Trials- Phase 3
7.4 Psoriatic Arthritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Psoriatic Arthritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Figure 9: Psoriatic Arthritis Clinical Trials by Phase
Figure 10: Psoriatic Arthritis Clinical Trials by Trial Status
Figure 11: Psoriatic Arthritis Clinical Trials by Type
Figure 12: Psoriatic Arthritis Clinical Trials by Sponsor Type
Figure 13: Psoriatic Arthritis Clinical Trials by Leading Sponsors
Figure 14: Psoriatic Arthritis Average Enrollment by Phase
Figure 15: Psoriatic Arthritis Average Enrollment by Trial Status
Figure 16: Psoriatic Arthritis Average Enrollment by Type
Figure 17: Psoriatic Arthritis- Average Enrolment by Type of Sponsors
Figure 18: Psoriatic Arthritis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Psoriatic Arthritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Table 7: North America - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Psoriatic Arthritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Psoriatic Arthritis Average Enrollment by Phase
Table 15: Psoriatic Arthritis Average Enrollment by Trial Status
Table 16: Psoriatic Arthritis Average Enrollment by Type
Table 17: Psoriatic Arthritis- Average Enrolment by Type of Sponsors
Table 18: Psoriatic Arthritis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc
  • Amgen Inc
  • C. H. Boehringer Sohn AG & Co KG
  • Celgene Corp
  • Eli Lilly and Co
  • Johnson & Johnson
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • UCB SA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768146
Adroll
adroll